2016 Q2 Form 10-K Financial Statement

#000114420416123313 Filed on September 09, 2016

View on sec.gov

Income Statement

Concept 2016 Q2 2016 2015 Q2
Revenue $1.120M $4.769M $1.341M
YoY Change -16.46% 3.54% 41.2%
Cost Of Revenue $1.170M $4.640M $1.140M
YoY Change 2.63% 4.53% 4.59%
Gross Profit -$48.00K $129.0K $205.0K
YoY Change -123.42% -22.75% -250.53%
Gross Profit Margin -4.29% 2.7% 15.29%
Selling, General & Admin $1.520M $5.139M $1.150M
YoY Change 32.17% 32.14% 16.16%
% of Gross Profit 3983.72% 561.08%
Research & Development $140.0K $528.0K $160.0K
YoY Change -12.5% -14.15% -20.0%
% of Gross Profit 409.3% 78.06%
Depreciation & Amortization $140.0K $471.0K $150.0K
YoY Change -6.67% -18.28% -16.67%
% of Gross Profit 365.12% 73.18%
Operating Expenses $1.200M $5.211M $1.300M
YoY Change -7.69% 15.7% 10.17%
Operating Profit -$1.248M -$5.082M -$1.095M
YoY Change 13.97% 17.18% -16.8%
Interest Expense $70.00K $1.000K $70.00K
YoY Change 0.0% -50.0% -119.44%
% of Operating Profit
Other Income/Expense, Net -$460.0K $371.0K $0.00
YoY Change -43.45%
Pretax Income -$1.180M -$4.711M -$1.030M
YoY Change 14.56% 27.97% -38.69%
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$1.185M -$4.711M -$1.035M
YoY Change 14.53% 27.98% -38.33%
Net Earnings / Revenue -105.8% -98.78% -77.17%
Basic Earnings Per Share
Diluted Earnings Per Share -$21.44K -$85.63K -$18.76K
COMMON SHARES
Basic Shares Outstanding 55.01M shares 54.91M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2016 Q2 2016 2015 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $12.39M $12.39M $14.59M
YoY Change -15.08% -15.1% -17.48%
Cash & Equivalents $10.14M $10.14M $5.227M
Short-Term Investments $2.250M $2.247M $9.360M
Other Short-Term Assets $27.00K $303.7K $26.69K
YoY Change 1.15% 15.22% 0.0%
Inventory $334.0K $334.4K $404.0K
Prepaid Expenses
Receivables $600.0K $604.9K $1.049M
Other Receivables $108.00 $110.00 $19.62K
Total Short-Term Assets $13.63M $13.63M $16.33M
YoY Change -16.52% -16.52% -15.04%
LONG-TERM ASSETS
Property, Plant & Equipment $577.0K $576.7K $574.8K
YoY Change 0.38% 1.37% -43.53%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $2.970M $2.973M $5.110M
YoY Change -41.88% -41.78% -5.37%
Other Assets $151.0K $772.0K $245.0K
YoY Change -38.38% 1.98% -7.21%
Total Long-Term Assets $4.473M $4.473M $6.678M
YoY Change -33.02% -33.02% -8.95%
TOTAL ASSETS
Total Short-Term Assets $13.63M $13.63M $16.33M
Total Long-Term Assets $4.473M $4.473M $6.678M
Total Assets $18.10M $18.10M $23.00M
YoY Change -21.31% -21.31% -13.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $610.0K $610.6K $500.0K
YoY Change 22.0% 22.55% -12.28%
Accrued Expenses $480.0K $482.7K $590.0K
YoY Change -18.64% -18.72% 1.72%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $1.094M $1.093M $1.092M
YoY Change 0.17% 0.1% -5.35%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $610.0K $607.5K $1.130M
YoY Change -46.02% -46.19% -21.53%
Total Long-Term Liabilities $610.0K $607.5K $1.130M
YoY Change -46.02% -46.19% -21.53%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.094M $1.093M $1.092M
Total Long-Term Liabilities $610.0K $607.5K $1.130M
Total Liabilities $1.701M $1.701M $2.221M
YoY Change -23.41% -23.42% -14.36%
SHAREHOLDERS EQUITY
Retained Earnings -$66.44M -$61.73M
YoY Change 7.63% 6.34%
Common Stock $82.84M $82.52M
YoY Change 0.39% 150757.52%
Preferred Stock
YoY Change
Treasury Stock (at cost) $0.00 $8.390K
YoY Change -100.0% 0.0%
Treasury Stock Shares 0.000 shares 13.20K shares
Shareholders Equity $16.40M $16.40M $20.78M
YoY Change
Total Liabilities & Shareholders Equity $18.10M $18.10M $23.00M
YoY Change -21.31% -21.31% -13.36%

Cashflow Statement

Concept 2016 Q2 2016 2015 Q2
OPERATING ACTIVITIES
Net Income -$1.185M -$4.711M -$1.035M
YoY Change 14.53% 27.98% -38.33%
Depreciation, Depletion And Amortization $140.0K $471.0K $150.0K
YoY Change -6.67% -18.28% -16.67%
Cash From Operating Activities -$1.200M -$3.884M -$630.0K
YoY Change 90.48% 10.28% -36.36%
INVESTING ACTIVITIES
Capital Expenditures -$230.0K $479.0K -$60.00K
YoY Change 283.33% 260.15% 200.0%
Acquisitions
YoY Change
Other Investing Activities $5.880M $9.249M $4.750M
YoY Change 23.79% 889.26% -130.84%
Cash From Investing Activities $5.660M $8.757M $4.700M
YoY Change 20.43% 1017.45% -130.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 0.000 39.00K 70.00K
YoY Change -100.0% -86.31% -82.05%
NET CHANGE
Cash From Operating Activities -1.200M -3.884M -630.0K
Cash From Investing Activities 5.660M 8.757M 4.700M
Cash From Financing Activities 0.000 39.00K 70.00K
Net Change In Cash 4.460M 4.912M 4.140M
YoY Change 7.73% -300.22% -125.84%
FREE CASH FLOW
Cash From Operating Activities -$1.200M -$3.884M -$630.0K
Capital Expenditures -$230.0K $479.0K -$60.00K
Free Cash Flow -$970.0K -$4.363M -$570.0K
YoY Change 70.18% 19.38% -41.24%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2016Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
108 USD
CY2015Q2 us-gaap Other Receivables Net Current
OtherReceivablesNetCurrent
19615 USD
CY2016Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
303734 USD
CY2015Q2 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
263597 USD
CY2016Q2 us-gaap Assets Current
AssetsCurrent
13629241 USD
CY2015Q2 us-gaap Assets Current
AssetsCurrent
16325522 USD
CY2016Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
576692 USD
CY2015Q2 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
574840 USD
CY2016Q2 us-gaap Long Term Investments
LongTermInvestments
2973348 USD
CY2015Q2 us-gaap Long Term Investments
LongTermInvestments
5106775 USD
CY2016Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181420 USD
CY2015Q2 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
181262 USD
CY2016Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
590616 USD
CY2015Q2 us-gaap Inventory Noncurrent
InventoryNoncurrent
569854 USD
CY2016Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
150533 USD
CY2015Q2 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
245031 USD
CY2016Q2 us-gaap Assets
Assets
18101850 USD
CY2015Q2 us-gaap Assets
Assets
23003284 USD
CY2016Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
610585 USD
CY2015Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
498253 USD
CY2016Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
122156 USD
CY2015Q2 us-gaap Accounts Payable And Other Accrued Liabilities Current
AccountsPayableAndOtherAccruedLiabilitiesCurrent
124131 USD
CY2016Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
177000 USD
CY2015Q2 us-gaap Other Liabilities Current
OtherLiabilitiesCurrent
129500 USD
CY2016 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55014922 shares
CY2016 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.09
CY2015 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.07
CY2016 us-gaap Gross Profit
GrossProfit
129154 USD
CY2016 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
49940 USD
CY2015 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
213248 USD
CY2016 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
39308 USD
CY2016Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
72220 USD
CY2015Q2 us-gaap Employee Related Liabilities Current
EmployeeRelatedLiabilitiesCurrent
212795 USD
CY2016Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
111356 USD
CY2015Q2 us-gaap Accrued Vacation Current
AccruedVacationCurrent
127515 USD
CY2016Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1093317 USD
CY2015Q2 us-gaap Liabilities Current
LiabilitiesCurrent
1092194 USD
CY2016Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
27000 USD
CY2015Q2 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
181000 USD
CY2016Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
580480 USD
CY2015Q2 us-gaap Asset Retirement Obligations Noncurrent
AssetRetirementObligationsNoncurrent
947849 USD
CY2016Q2 us-gaap Common Stock Value
CommonStockValue
55010 USD
CY2015Q2 us-gaap Common Stock Value
CommonStockValue
54968 USD
CY2016Q2 us-gaap Treasury Stock Value
TreasuryStockValue
0 USD
CY2015Q2 us-gaap Treasury Stock Value
TreasuryStockValue
8390 USD
CY2016Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82788299 USD
CY2015Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
82467111 USD
CY2016Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-66442315 USD
CY2015Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-61731507 USD
CY2016Q2 us-gaap Stockholders Equity
StockholdersEquity
16401053 USD
CY2015Q2 us-gaap Stockholders Equity
StockholdersEquity
20782241 USD
CY2016Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
18101850 USD
CY2015Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
23003284 USD
CY2016Q2 us-gaap Liabilities
Liabilities
1700797 USD
CY2015Q2 us-gaap Liabilities
Liabilities
2221043 USD
CY2016 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4769276 USD
CY2015 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4606539 USD
CY2016 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4640122 USD
CY2015 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4439146 USD
CY2015 us-gaap Gross Profit
GrossProfit
167393 USD
CY2016 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
528049 USD
CY2015 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
614771 USD
CY2016 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1352735 USD
CY2015 us-gaap Selling And Marketing Expense
SellingAndMarketingExpense
1488456 USD
CY2016 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
3786657 USD
CY2015 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2400353 USD
CY2016 us-gaap Operating Expenses
OperatingExpenses
5211157 USD
CY2015 us-gaap Operating Expenses
OperatingExpenses
4503580 USD
CY2016 us-gaap Operating Income Loss
OperatingIncomeLoss
-5082003 USD
CY2015 us-gaap Operating Income Loss
OperatingIncomeLoss
-4336187 USD
CY2016 us-gaap Investment Income Interest
InvestmentIncomeInterest
218145 USD
CY2015 us-gaap Investment Income Interest
InvestmentIncomeInterest
282745 USD
CY2016 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
154000 USD
CY2015 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
374605 USD
CY2016 us-gaap Interest Expense
InterestExpense
950 USD
CY2015 us-gaap Interest Expense
InterestExpense
2214 USD
CY2016 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
371195 USD
CY2015 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
655136 USD
CY2016 us-gaap Net Income Loss
NetIncomeLoss
-4710808 USD
CY2015 us-gaap Net Income Loss
NetIncomeLoss
-3681051 USD
CY2016 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10632 USD
CY2015 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10632 USD
CY2016 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4721440 USD
CY2015 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-3691683 USD
CY2015 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
284865 USD
CY2016 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4912286 USD
CY2015 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-2453333 USD
CY2014Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
7680073 USD
CY2016 isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
0 USD
CY2015 isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
17395 USD
CY2016 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
CY2015 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
CY2016 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-6512 USD
CY2015 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2016 us-gaap Inventory Write Down
InventoryWriteDown
72200 USD
CY2015 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2014 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
13992 USD
CY2016 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
109622 USD
CY2015 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
4794674 USD
CY2016 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
158 USD
CY2015 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
54 USD
CY2016 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
8756978 USD
CY2015 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
783660 USD
CY2016 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
CY2015 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
82249 USD
CY2015 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
127385 USD
CY2016 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
23402 USD
CY2015 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
144314 USD
CY2016 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-19507 USD
CY2015 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
-33467 USD
CY2015 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54882350 shares
CY2014 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
4219158 USD
CY2014 us-gaap Cost Of Goods Sold
CostOfGoodsSold
4415629 USD
CY2014 us-gaap Gross Profit
GrossProfit
-196471 USD
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2488219 USD
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
12113 USD
CY2014 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-1382134 USD
CY2014 us-gaap Interest Expense
InterestExpense
883 USD
CY2014 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-1370904 USD
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-5959122 USD
CY2014 us-gaap Preferred Stock Dividends Income Statement Impact
PreferredStockDividendsIncomeStatementImpact
10632 USD
CY2014 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6696132 USD
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.16
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
42675158 shares
CY2016 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
0 USD
CY2015 isr Provision For Reduction Of Doubtful Accounts
ProvisionForReductionOfDoubtfulAccounts
8607 USD
CY2016 us-gaap Adjustment For Amortization
AdjustmentForAmortization
107037 USD
CY2015 us-gaap Adjustment For Amortization
AdjustmentForAmortization
36987 USD
CY2016 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
88915 USD
CY2015 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
81289 USD
CY2016 us-gaap Share Based Compensation
ShareBasedCompensation
290312 USD
CY2015 us-gaap Share Based Compensation
ShareBasedCompensation
205264 USD
CY2016 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-444174 USD
CY2016 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
12539 USD
CY2015 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17942 USD
CY2016 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
15491539 USD
CY2015 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
15873376 USD
CY2016 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
6133027 USD
CY2015 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10143741 USD
CY2014 us-gaap Depreciation And Amortization
DepreciationAndAmortization
685396 USD
CY2014 us-gaap Adjustment For Amortization
AdjustmentForAmortization
30189 USD
CY2014 us-gaap Asset Retirement Obligation Accretion Expense
AssetRetirementObligationAccretionExpense
74318 USD
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
185987 USD
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-24723 USD
CY2014 us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-45834 USD
CY2014 us-gaap Increase Decrease In Other Receivables
IncreaseDecreaseInOtherReceivables
41580 USD
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3167 USD
CY2014 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
142289 USD
CY2014 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
55128 USD
CY2014 us-gaap Increase Decrease In Other Current Liabilities
IncreaseDecreaseInOtherCurrentLiabilities
41592 USD
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
108863 USD
CY2014 us-gaap Increase Decrease In Other Employee Related Liabilities
IncreaseDecreaseInOtherEmployeeRelatedLiabilities
13187 USD
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-3228221 USD
CY2014 us-gaap Payments To Acquire Intangible Assets
PaymentsToAcquireIntangibleAssets
17758 USD
CY2014 us-gaap Proceeds From Sale Of Short Term Investments
ProceedsFromSaleOfShortTermInvestments
0 USD
CY2014 us-gaap Payments To Acquire Short Term Investments
PaymentsToAcquireShortTermInvestments
10002912 USD
CY2014 us-gaap Payments To Acquire Longterm Investments
PaymentsToAcquireLongtermInvestments
5401398 USD
CY2014 us-gaap Increase Decrease In Restricted Cash
IncreaseDecreaseInRestrictedCash
59 USD
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-15441156 USD
CY2014 us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
6099807 USD
CY2015Q2 us-gaap Inventory Finished Goods
InventoryFinishedGoods
55526 USD
CY2016Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7541126 USD
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
266314 USD
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
23449523 USD
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
4780146 USD
CY2013Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2899927 USD
CY2014 isr Supplemental Common Stock Warrant Liability Reclassification
SupplementalCommonStockWarrantLiabilityReclassification
-913134 USD
CY2014 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
CY2014 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
0 USD
CY2014 us-gaap Inventory Write Down
InventoryWriteDown
0 USD
CY2016 isr Federal Deposit Insurance Corporation Limits On Deposits In Financial Institutions
FederalDepositInsuranceCorporationLimitsOnDepositsInFinancialInstitutions
250000 USD
CY2015Q2 us-gaap Inventory Raw Materials
InventoryRawMaterials
143669 USD
CY2015Q2 us-gaap Inventory Work In Process
InventoryWorkInProcess
204760 USD
CY2015Q2 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
7114836 USD
CY2016Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
8117818 USD
CY2015Q2 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
7689676 USD
CY2016 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
290312 USD
CY2015 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
205264 USD
CY2014 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
185987 USD
CY2016Q2 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized
787245 USD
CY2016 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P1Y10M24D
CY2016Q2 isr Percentage Of Royalty Rate Payable
PercentageOfRoyaltyRatePayable
0.01 pure
CY2016Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 USD
CY2015Q2 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
30000 USD
CY2016Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2015Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
7001671 shares
CY2016Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2015Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2016Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2015Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
192998329 shares
CY2016Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
55010619 shares
CY2016 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
80938 USD
CY2015 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
25226 USD
CY2014 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
18468 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
17612 USD
CY2014Q4 us-gaap Gross Profit
GrossProfit
-37964 USD
CY2015Q1 us-gaap Gross Profit
GrossProfit
55197 USD
CY2015Q2 us-gaap Gross Profit
GrossProfit
204962 USD
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-785862 USD
CY2015Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2016Q2 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2015Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1261322 USD
CY2015Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1189008 USD
CY2016Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1198701 USD
CY2015Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
54967559 shares
CY2015Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
54967559 shares
CY2016Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
55010619 shares
CY2016Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
0 shares
CY2015Q2 us-gaap Treasury Stock Shares
TreasuryStockShares
13200 shares
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-906954 USD
CY2016 us-gaap Use Of Estimates
UseOfEstimates
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><u><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">Use of Estimates</font></u></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt"> &#160;</font></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;LINE-HEIGHT: normal; MARGIN: 0in 0in 0pt" align="justify"><font style="FONT-FAMILY: 'Times New Roman','serif'; FONT-SIZE: 10pt">The preparation of consolidated financial statements in accordance with generally accepted accounting principles in the United States of America requires management of the Company to make estimates and assumptions that affect the amounts reported in the consolidated financial statements and accompanying notes of the Company including the allowance for doubtful accounts receivable; net realizable value of the enriched barium inventory; the estimated useful lives used in calculating depreciation and amortization on the Company's fixed assets, patents, trademarks and other assets; estimated amount and fair value of the asset retirement obligation related to the Company's production facilities; inputs used in the calculation of expense related to share-based compensation including volatility, estimated lives and forfeiture rates of options granted; and the inputs to the Black-Scholes calculation to estimate the fair value of the derivative warrant liability and the related gain or loss. Accordingly, actual results could differ from those estimates and affect the amounts reported in the financial statements.</font></div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2016 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
456284 USD
CY2015 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 USD
CY2014 us-gaap Asset Retirement Obligation Revision Of Estimate
AssetRetirementObligationRevisionOfEstimate
0 USD
CY2016 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
0 USD
CY2015 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
0 USD
CY2014 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2016 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
157347 USD
CY2014 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
114313 USD
CY2015 us-gaap Marketing And Advertising Expense
MarketingAndAdvertisingExpense
151197 USD
CY2015Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
9600 USD
CY2016Q2 us-gaap Prepaid Advertising
PrepaidAdvertising
12222 USD
CY2016 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
3214211 shares
CY2015 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2863147 shares
CY2014 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2818234 shares
CY2016Q2 us-gaap Prepaid Insurance
PrepaidInsurance
46108 USD
CY2015Q2 us-gaap Prepaid Insurance
PrepaidInsurance
30578 USD
CY2016Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
230933 USD
CY2015Q2 us-gaap Other Prepaid Expense Current
OtherPrepaidExpenseCurrent
206326 USD
CY2016Q2 us-gaap Other Assets Current
OtherAssetsCurrent
26693 USD
CY2015Q2 us-gaap Other Assets Current
OtherAssetsCurrent
26693 USD
CY2015Q1 us-gaap Net Income Loss
NetIncomeLoss
-953553 USD
CY2015Q2 us-gaap Net Income Loss
NetIncomeLoss
-1034682 USD
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1120245 USD
CY2015Q3 us-gaap Gross Profit
GrossProfit
83459 USD
CY2015Q4 us-gaap Gross Profit
GrossProfit
26911 USD
CY2016Q1 us-gaap Gross Profit
GrossProfit
66304 USD
CY2016Q2 us-gaap Gross Profit
GrossProfit
-47520 USD
CY2015Q3 us-gaap Net Income Loss
NetIncomeLoss
-1019110 USD
CY2015Q4 us-gaap Net Income Loss
NetIncomeLoss
-1311588 USD
CY2016Q1 us-gaap Net Income Loss
NetIncomeLoss
-1195297 USD
CY2016Q2 us-gaap Net Income Loss
NetIncomeLoss
-1184813 USD
CY2015Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2016Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2015Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55012901 shares
CY2015Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55013553 shares
CY2016Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55022668 shares
CY2016Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
55010619 shares
CY2014Q3 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1042101 USD
CY2014Q4 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1065585 USD
CY2015Q1 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1158109 USD
CY2015Q2 us-gaap Sales Revenue Goods Net
SalesRevenueGoodsNet
1340744 USD
CY2014Q3 us-gaap Gross Profit
GrossProfit
-54802 USD
CY2014Q3 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54868053 shares
CY2014Q4 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54883445 shares
CY2015Q1 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54883551 shares
CY2015Q2 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
54900828 shares
CY2016 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
479215 USD
CY2015 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
133305 USD
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
19029 USD
CY2016 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2015 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
0 USD
CY2014 us-gaap Proceeds From Issuance Of Preferred Stock And Preference Stock
ProceedsFromIssuanceOfPreferredStockAndPreferenceStock
1478703 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
150533 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
198490 USD
CY2016 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
63762 USD
CY2015 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
0 USD
CY2014 isr Increase Decrease In Estimate On Patents And Trademarks
IncreaseDecreaseInEstimateOnPatentsAndTrademarks
0 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
282484 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
282484 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
235403 USD
CY2016Q2 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
800371 USD
CY2016 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
292350 USD
CY2015 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
280007 USD
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
276395 USD
CY2016 isr Amortization Expense On Patents And Trademarks
AmortizationExpenseOnPatentsAndTrademarks
17176 USD
CY2015 isr Amortization Expense On Patents And Trademarks
AmortizationExpenseOnPatentsAndTrademarks
25226 USD
CY2014 isr Amortization Expense On Patents And Trademarks
AmortizationExpenseOnPatentsAndTrademarks
18468 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
17152 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
16905 USD
CY2016 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2015 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
0 USD
CY2014 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
1800589 USD
CY2016 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
6000 USD
CY2015 us-gaap Related Party Transaction Selling General And Administrative Expenses From Transactions With Related Party
RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty
12000 USD
CY2016 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
0 USD
CY2015 us-gaap Cost Of Property Repairs And Maintenance
CostOfPropertyRepairsAndMaintenance
0 USD
CY2016Q2 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
0 USD
CY2016 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
6000 USD
CY2015 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
12000 USD
CY2014 us-gaap Other Selling And Marketing Expense
OtherSellingAndMarketingExpense
12000 USD
CY2016 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2015 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 USD
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
13814742 USD
CY2016 us-gaap Interest Paid
InterestPaid
950 USD
CY2015 us-gaap Interest Paid
InterestPaid
2214 USD
CY2014 us-gaap Interest Paid
InterestPaid
748 USD
CY2016 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2015 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
0 USD
CY2014 us-gaap Conversion Of Stock Amount Converted1
ConversionOfStockAmountConverted1
-1478703 USD
CY2016 isr Noncashinvestingandfinancingitemdeemedpreferredstockdividend
Noncashinvestingandfinancingitemdeemedpreferredstockdividend
0 USD
CY2015 isr Noncashinvestingandfinancingitemdeemedpreferredstockdividend
Noncashinvestingandfinancingitemdeemedpreferredstockdividend
0 USD
CY2014 isr Noncashinvestingandfinancingitemdeemedpreferredstockdividend
Noncashinvestingandfinancingitemdeemedpreferredstockdividend
-726378 USD
CY2015Q2 us-gaap Deferred Costs
DeferredCosts
46541 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
16368 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
16368 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
66128 USD
CY2015Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
947849 USD
CY2014Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
866560 USD
CY2016 isr Asset Retirement Obligation Period Increase Decrease In Estimate Gain Loss
AssetRetirementObligationPeriodIncreaseDecreaseInEstimateGainLoss
-456284 USD
CY2015 isr Asset Retirement Obligation Period Increase Decrease In Estimate Gain Loss
AssetRetirementObligationPeriodIncreaseDecreaseInEstimateGainLoss
81289 USD
CY2016Q2 us-gaap Asset Retirement Obligation
AssetRetirementObligation
580480 USD
CY2016 isr Asset Retirement Obligation Assumed Inflation Factor
AssetRetirementObligationAssumedInflationFactor
0.011 pure
CY2016 isr Asset Retirement Obligation Assumed Creditadjusted Risk Free Rate
AssetRetirementObligationAssumedCreditadjustedRiskFreeRate
0.051 pure
CY2014 isr Preferred Stock Issued During Period Value New Issues
PreferredStockIssuedDuringPeriodValueNewIssues
1478703 USD
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1800589 USD
CY2014 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
7012941 USD
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
266314 USD
CY2014 isr Issuance Of Common Stock And Warrants Value
IssuanceOfCommonStockAndWarrantsValue
13814742 USD
CY2014 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10632 USD
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
185987 USD
CY2015 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
99644 USD
CY2015 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
213248 USD
CY2016 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
49940 USD
CY2016 us-gaap Treasury Stock Retired Cost Method Amount
TreasuryStockRetiredCostMethodAmount
0 USD
CY2016 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
290312 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
1185500 shares
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
13000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Loss Reserves
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsLossReserves
11000 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
119000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Other
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsOther
85000 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
203000 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
395000 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Shares Issued In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesIssuedInPeriod
430000 shares
CY2016 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10632 USD
CY2015 us-gaap Dividends Preferred Stock Cash
DividendsPreferredStockCash
10632 USD
CY2015 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
205264 USD
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0051 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0162 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0142 pure
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0165 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.0148 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.0185 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.06 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.18 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.06 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.32 pure
CY2014 us-gaap Conversion Of Stock Amount Issued1
ConversionOfStockAmountIssued1
0 USD
CY2016Q2 us-gaap Purchase Obligation
PurchaseObligation
1000000 USD
CY2016Q2 us-gaap Purchase Obligation Due In Next Twelve Months
PurchaseObligationDueInNextTwelveMonths
590000 USD
CY2016Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
610000 USD
CY2015Q2 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
546000 USD
CY2016Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
545000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
443000 USD
CY2015Q2 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Asset Retirement Obligations
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAssetRetirementObligations
332000 USD
CY2016Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
19110000 USD
CY2015Q2 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17508000 USD
CY2016Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
20600000 USD
CY2015Q2 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
18925000 USD
CY2016Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
20600000 USD
CY2015Q2 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
18925000 USD
CY2016Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2015Q2 us-gaap Deferred Tax Assets Net
DeferredTaxAssetsNet
0 USD
CY2016 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1649000 USD
CY2015 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-1288000 USD
CY2014 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-2086000 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
7000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
10000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Meals And Entertainment
IncomeTaxReconciliationNondeductibleExpenseMealsAndEntertainment
10000 USD
CY2016 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
21000 USD
CY2015 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
19000 USD
CY2014 us-gaap Income Tax Reconciliation Nondeductible Expense Other
IncomeTaxReconciliationNondeductibleExpenseOther
9000 USD
CY2016 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-54000 USD
CY2015 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
-131000 USD
CY2015 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y11M5D
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M8D
CY2015 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P4Y8M16D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y11M5D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1
P6Y10M17D
CY2016 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageRemainingContractualTerm1
P6Y8M23D
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
115302 USD
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
3186916 USD
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
691789 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
0.61
CY2014 isr Income Tax Reconciliation Change In Fair Value Of Warrants
IncomeTaxReconciliationChangeInFairValueOfWarrants
484000 USD
CY2016 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1675000 USD
CY2015 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1390000 USD
CY2014 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
1583000 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2686525 shares
CY2016 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2015 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
2561194 shares
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
1.20
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.18
CY2016 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.35 pure
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
262557 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue
256233 USD
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue
250373 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
19667 shares
CY2016 isr Purchase Obligation Expiration Date
PurchaseObligationExpirationDate
2017-03-31
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
350983 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.76
CY2015 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
206904 shares
CY2016 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
56260 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.89
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
1.03
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
84236 shares
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
4.15
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice
3.48
CY2016Q2 isr Commitment Cpi
CommitmentCpi
0.007 pure
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
162869 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod
459594 shares
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
1.67
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.81
CY2015 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
1.41
CY2016 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.87
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
395000 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
1185500 shares
CY2016 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
24595 USD
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
306620 USD
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
548928 USD
CY2013Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
1957033 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
444747 shares
CY2015Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
385800 shares
CY2016Q2 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
230087 shares
CY2013Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.38
CY2016 isr Class Of Warrant Or Right Expired In Period
ClassOfWarrantOrRightExpiredInPeriod
155713 shares
CY2016 isr Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights
Classofwarrantorrightexpiredinperiodweightedaverageexercisepriceofwarrantsorrights
1.63
CY2015 isr Issuanceofcommonstockinconnectionwithwarrantexercisesnetofissuancecostsshares
Issuanceofcommonstockinconnectionwithwarrantexercisesnetofissuancecostsshares
58947 shares
CY2014 isr Issuanceofcommonstockinconnectionwithwarrantexercisesnetofissuancecostsshares
Issuanceofcommonstockinconnectionwithwarrantexercisesnetofissuancecostsshares
7165443 shares
CY2014Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.43
CY2015Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
1.22
CY2016Q2 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
0.94
CY2016 isr Warrantsexpirationmonthandyear
Warrantsexpirationmonthandyear
Expiration
CY2015 us-gaap Payments Of Dividends Preferred Stock And Preference Stock
PaymentsOfDividendsPreferredStockAndPreferenceStock
10632 USD
CY2014 isr Class Of Warrant Or Right Corrected In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightCorrectedInPeriodExercisePriceOfWarrantsOrRights
1.31
CY2014 isr Class Of Warrant Or Right Corrected
ClassOfWarrantOrRightCorrected
26939 shares
CY2014 isr Issuance Of Common Stock In Connection With Cash Less Warrant Exercises
IssuanceOfCommonStockInConnectionWithCashLessWarrantExercises
22520 shares
CY2014 isr Class Of Warrant Or Right Grants In Period
ClassOfWarrantOrRightGrantsInPeriod
5648738 shares
CY2014 isr Class Of Warrant Or Right Redeemed In Cashless Exercise In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightRedeemedInCashlessExerciseInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.96
CY2015 isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
1.38
CY2014 isr Class Of Warrant Or Right Issued In Period Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightIssuedInPeriodExercisePriceOfWarrantsOrRights
0.86
CY2014 isr Class Of Warrant Or Right Grants In Period Weighted Average Exercise Price Of Warrants Or Rights
ClassOfWarrantOrRightGrantsInPeriodWeightedAverageExercisePriceOfWarrantsOrRights
0.72
CY2013Q3 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
3700000 shares
CY2013Q3 us-gaap Preferred Stock Redemption Premium
PreferredStockRedemptionPremium
726378 USD
CY2013Q3 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
3279292 USD
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
38419502 shares
CY2014Q1 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
41540982 shares
CY2014Q1 isr Gross Proceeds From Issuance Of Stock
GrossProceedsFromIssuanceOfStock
14675180 shares
CY2014Q1 us-gaap Proceeds From Issuance Or Sale Of Equity
ProceedsFromIssuanceOrSaleOfEquity
13814742 USD
CY2013Q2 us-gaap Stockholders Equity
StockholdersEquity
5366246 USD
CY2014Q2 us-gaap Stockholders Equity
StockholdersEquity
23955768 USD
CY2016 us-gaap Nature Of Operations
NatureOfOperations
<div style="MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif "> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"></div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt"> <table style="MARGIN-TOP: 0px; FONT: 10pt Times New Roman, Times, Serif; MARGIN-BOTTOM: 0px" cellspacing="0" cellpadding="0" width="100%"> <tr style="VERTICAL-ALIGN: top"> <td style="WIDTH: 0px"></td> <td style="WIDTH: 0.25in"> <div><b>1.</b></div> </td> <td style="TEXT-ALIGN: left"> <div><b>Organization</b></div> </td> </tr> </table> </div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;MARGIN: 0px; FONT: 10pt Times New Roman, Times, Serif" align="left">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">IsoRay, Inc. was incorporated in Minnesota in 1983. On July 28, 2005, IsoRay Medical, Inc. (Medical) became a wholly-owned subsidiary of IsoRay, Inc. (formerly known as Century Park Pictures Corporation) pursuant to a merger. Medical was formed under Delaware law on June 15, 2004 and on October 1, 2004 acquired two affiliated predecessor companies which began operations in 1998. Medical, a Delaware corporation, develops, manufactures and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Medical is headquartered in Richland, Washington.</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">&#160;</div> <div style="CLEAR:both; FONT-FAMILY:Times New Roman;FONT-SIZE: 10pt;TEXT-INDENT: 0in; MARGIN: 0pt 0px; FONT: 10pt Times New Roman, Times, Serif" align="justify">IsoRay International LLC (International), a Washington limited liability company, was formed on November 27, 2007 and is a wholly-owned subsidiary of the IsoRay, Inc. International has entered into various international distribution agreements.</div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2015 us-gaap Depreciation
Depreciation
576380 USD
CY2016 us-gaap Depreciation
Depreciation
470851 USD
CY2014 us-gaap Depreciation
Depreciation
685396 USD
CY2016Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
215497 USD
CY2015Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
134559 USD
CY2016 isr Purchase Obligation Agreement Period
PurchaseObligationAgreementPeriod
P1Y
CY2015 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
1.07 pure
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice
1.47
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2925059 shares
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.83
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
2.00
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.91
CY2016Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.21
CY2016Q2 us-gaap Area Of Land
AreaOfLand
4.2 acre
CY2016Q2 isr Number Of Employees Commitment
NumberOfEmployeesCommitment
25 pure
CY2016Q2 isr Estimated Asset Retirement Cost
EstimatedAssetRetirementCost
650000 USD
CY2016 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
51071 USD
CY2015 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
10359 USD
CY2014 us-gaap Property Plant And Equipment Disposals
PropertyPlantAndEquipmentDisposals
59723 USD
CY2013Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2305072 shares
CY2014Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2314422 shares
CY2015Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2418282 shares
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
380000 shares

Files In Submission

Name View Source Status
0001144204-16-123313-index-headers.html Edgar Link pending
0001144204-16-123313-index.html Edgar Link pending
0001144204-16-123313.txt Edgar Link pending
0001144204-16-123313-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
isr-20160630.xml Edgar Link completed
isr-20160630.xsd Edgar Link pending
isr-20160630_cal.xml Edgar Link unprocessable
isr-20160630_def.xml Edgar Link unprocessable
isr-20160630_lab.xml Edgar Link unprocessable
isr-20160630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R74.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
tpg11.jpg Edgar Link pending
tpg41.jpg Edgar Link pending
v448322_10k.htm Edgar Link pending
v448322_ex10-93.htm Edgar Link pending
v448322_ex21-1.htm Edgar Link pending
v448322_ex23-1.htm Edgar Link pending
v448322_ex31-1.htm Edgar Link pending
v448322_ex31-2.htm Edgar Link pending
v448322_ex32.htm Edgar Link pending